CIPLA LTD.
Hepcvir-l
HEPCVIR-L is a fixed-dose combination of “LEDIPASVIR AND SOFOSBUVIR” which are direct acting antiviral agents against the hepatitis C virus (HCV). Ledipasvir is an inhibitor of the protein, which is required for viral replication. Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridine analog triphosphate which can be incorporated into HCV RNA and acts as a chain terminator.
Indication
HEPCVIR-L is used for the treatment of chronic hepatitis C virus (HCV).
Note
Precaution
HEPCVIR-L is a prescription drug and should be used under proper medical guidance and advice.
Updated On Oct 19, 2019 by AdminStrength
90 mg Ledipasvir /400 mg Sofosbuvir
Packing
1*28 Tablets (Bottle)
Storage
Store at a temperature not exceeding 30 C
Was this page helpful?
Related Products
NATCO PHARMA LIMITED (INDIA)
Velpanat
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
Hetero Healthcare Ltd. (INDIA)
Ledifos
Mylan
Mydacla
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)